Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8+ T Cells. 2018

Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands.

Human lymphoid tissues harbor, in addition to CD56bright and CD56dim natural killer (NK) cells, a third NK cell population: CD69+CXCR6+ lymphoid tissue (lt)NK cells. The function and development of ltNK cells remain poorly understood. In this study, we performed RNA sequencing on the three NK cell populations derived from bone marrow (BM) and blood. In ltNK cells, 1,353 genes were differentially expressed compared to circulating NK cells. Several molecules involved in migration were downregulated in ltNK cells: S1PR1, SELPLG and CD62L. By flow cytometry we confirmed that the expression profile of adhesion molecules (CD49e-, CD29low, CD81high, CD62L-, CD11c-) and transcription factors (Eomeshigh, Tbetlow) of ltNK cells differed from their circulating counterparts. LtNK cells were characterized by enhanced expression of inhibitory receptors TIGIT and CD96 and low expression of DNAM1 and cytolytic molecules (GZMB, GZMH, GNLY). Their proliferative capacity was reduced compared to the circulating NK cells. By performing gene set enrichment analysis, we identified DUSP6 and EGR2 as potential regulators of the ltNK cell transcriptome. Remarkably, comparison of the ltNK cell transcriptome to the published human spleen-resident memory CD8+ T (Trm) cell transcriptome revealed an overlapping gene signature. Moreover, the phenotypic profile of ltNK cells resembled that of CD8+ Trm cells in BM. Together, we provide transcriptional and phenotypic data that clearly distinguish ltNK cells from both the CD56bright and CD56dim NK cells and substantiate the view that ltNK cells are tissue-resident cells, which are functionally restrained in killing and have low proliferative activity.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D059467 Transcriptome The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells. Transcriptomes,Gene Expression Profiles,Gene Expression Signatures,Transcriptome Profiles,Expression Profile, Gene,Expression Profiles, Gene,Expression Signature, Gene,Expression Signatures, Gene,Gene Expression Profile,Gene Expression Signature,Profile, Gene Expression,Profile, Transcriptome,Profiles, Gene Expression,Profiles, Transcriptome,Signature, Gene Expression,Signatures, Gene Expression,Transcriptome Profile

Related Publications

Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
January 2013, Genes and immunity,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
April 2018, Current opinion in immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
March 2024, Rheumatology (Oxford, England),
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
January 2017, Frontiers in immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
July 2022, Nature immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
July 2023, Nature immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
January 2018, Frontiers in immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
July 2000, The Journal of allergy and clinical immunology,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
June 2018, Zeitschrift fur Rheumatologie,
Janine E Melsen, and Gertjan Lugthart, and Carly Vervat, and Szymon M Kielbasa, and Sander A J van der Zeeuw, and Henk P J Buermans, and Monique M van Ostaijen-Ten Dam, and Arjan C Lankester, and Marco W Schilham
July 2017, Scientific reports,
Copied contents to your clipboard!